|
US4496542A
(en)
|
1981-03-30 |
1985-01-29 |
Usv Pharmaceutical Corporation |
N-substituted-amido-amino acids
|
|
US20240390418A1
(en)
|
1997-09-04 |
2024-11-28 |
Minerva Biotechnologies Corporation |
Anti-variable muc1* antibodies and uses thereof
|
|
AU3347900A
(en)
|
1999-01-23 |
2000-08-07 |
Minerva Biotechnologies Corporation |
Interaction of colloid-immobilized species with species on non-colloidal structures
|
|
AU3474100A
(en)
|
1999-01-25 |
2000-08-07 |
Minerva Biotechnologies Corporation |
Rapid and sensitive detection of aberrant protein aggregation in neurodegenerative diseases
|
|
WO2002001230A2
(en)
|
2000-06-23 |
2002-01-03 |
Minerva Biotechnologies Corporation |
Rapid and sensitive detection of protein aggregation
|
|
AU2001265403A1
(en)
|
2000-05-26 |
2001-12-11 |
Minerva Biotechnologies Corporation |
Metallocenes as signal-transducer for detection of chemical or biological events
|
|
WO2002001228A2
(en)
|
2000-06-23 |
2002-01-03 |
Minerva Biotechnologies Corporation |
Interaction of colloid-immobilized species with species on non-colloidal structures
|
|
JP4585170B2
(ja)
|
2000-10-03 |
2010-11-24 |
ミナーヴァ・バイオテクノロジーズ・コーポレーション |
流動の中断に基づく相互作用の電子検出および相互作用の検出
|
|
AU2002219971A1
(en)
|
2000-11-01 |
2002-05-15 |
Minerva Biotechnologies Corporation |
Detection of binding species with colloidal and non-colloidal structures
|
|
JP4516273B2
(ja)
|
2000-11-15 |
2010-08-04 |
ミナーヴァ・バイオテクノロジーズ・コーポレーション |
オリゴヌクレオチド識別子
|
|
EP2241887B1
(en)
|
2000-11-27 |
2015-01-14 |
Minerva Biotechnologies Corporation |
Diagnostics, drug screening and treatment for cancer
|
|
MXPA05000511A
(es)
|
2001-07-12 |
2005-09-30 |
Jefferson Foote |
Anticuepros super humanizados.
|
|
WO2003018846A1
(en)
|
2001-08-31 |
2003-03-06 |
Minerva Biotechnologies Corporation |
Affinity tag modified particles
|
|
EP2329822A1
(en)
|
2001-09-05 |
2011-06-08 |
Minerva Biotechnologies Corporation |
Compositions and methods of treatment of cancer
|
|
WO2003020280A2
(en)
|
2001-09-05 |
2003-03-13 |
Minerva Biotechnologies Corporation |
Compositions and use thereof in the treatment of cancer
|
|
CA2537263C
(en)
|
2002-11-27 |
2017-05-30 |
Minerva Biotechnologies Corporation |
Techniques and compositions for the diagnosis and treatment of cancer (muc1)
|
|
JP2006517674A
(ja)
|
2002-12-20 |
2006-07-27 |
ミネルバ バイオテクノロジーズ コーポレーション |
ナノ粒子を含む光学デバイスおよび方法
|
|
EP2478912B1
(en)
|
2003-11-06 |
2016-08-31 |
Seattle Genetics, Inc. |
Auristatin conjugates with anti-HER2 or anti-CD22 antibodies and their use in therapy
|
|
CA2584412C
(en)
|
2004-09-14 |
2017-05-09 |
Minerva Biotechnologies Corporation |
Methods for diagnosis and treatment of cancer
|
|
ES2720288T3
(es)
|
2005-03-30 |
2019-07-19 |
Minerva Biotechnologies Corp |
Proliferación de células que expresan MUC1
|
|
EP2526957A3
(en)
|
2005-03-30 |
2013-02-20 |
Minerva Biotechnologies Corporation |
Proliferation of MUC1 expressing cells
|
|
US20090075926A1
(en)
|
2006-12-06 |
2009-03-19 |
Bamdad Cynthia C |
Method for identifying and manipulating cells
|
|
US20090092603A1
(en)
|
2007-09-25 |
2009-04-09 |
Bamdad Cynthia C |
Early diagnosis and treatment of drug resistance in muc1-positive cancer
|
|
EP2214485B1
(en)
|
2007-09-25 |
2016-07-20 |
Minerva Biotechnologies Corp. |
Methods for treatment of cancer
|
|
US11202775B2
(en)
|
2007-09-25 |
2021-12-21 |
Minerva Biotechnologies Corporation |
Methods for treatment of cancer
|
|
EP3130607B1
(en)
|
2008-10-06 |
2024-04-17 |
Minerva Biotechnologies Corporation |
Muc1* antibodies
|
|
CN102272290B
(zh)
|
2008-10-09 |
2018-08-14 |
米纳瓦生物技术公司 |
用于在细胞中诱导多能性的方法
|
|
ES3000111T3
(en)
|
2009-02-13 |
2025-02-27 |
Immunomedics Inc |
Intermediates for preparing conjugates with an intracellularly-cleavable linkage
|
|
MX2011013385A
(es)
|
2009-06-11 |
2012-05-29 |
Minerva Biotechnologies Corp |
Metodos para cultivar celulas madre y celulas progenitoras.
|
|
EP3228629A1
(en)
|
2010-06-16 |
2017-10-11 |
Minerva Biotechnologies Corporation |
Reprogramming cancer cells
|
|
EP2686418A4
(en)
|
2011-03-17 |
2015-04-22 |
Minerva Biotechnologies Corp |
METHOD FOR THE PRODUCTION OF PLURIPOTENTAL STEM CELLS
|
|
WO2012154759A2
(en)
|
2011-05-09 |
2012-11-15 |
Minerva Biotechnologies Corporation |
Genetically engineered growth factor variants
|
|
CN109456932A
(zh)
|
2011-10-17 |
2019-03-12 |
米纳瓦生物技术公司 |
用于干细胞增殖和诱导的培养基
|
|
US20240247229A1
(en)
|
2011-10-17 |
2024-07-25 |
Minerva Biotechnologies Corporation |
Media for stem cell proliferation and induction
|
|
WO2013123084A1
(en)
|
2012-02-13 |
2013-08-22 |
Minerva Biotechnologies Corporation |
Method for detecting circulating fetal cells
|
|
US9708388B2
(en)
|
2012-04-11 |
2017-07-18 |
Hoffmann-La Roche Inc. |
Antibody light chains
|
|
AU2013289913A1
(en)
|
2012-07-13 |
2015-03-05 |
Minerva Biotechnologies Corporation |
Method for inducing cells to less mature state
|
|
WO2014018679A2
(en)
|
2012-07-24 |
2014-01-30 |
Minerva Biotechnologies Corporation |
Nme variant species expression and suppression
|
|
WO2014028668A2
(en)
|
2012-08-14 |
2014-02-20 |
Minerva Biotechnologies Corporation |
Stem cell enhancing therapeutics
|
|
ES2773710T3
(es)
|
2012-10-11 |
2020-07-14 |
Daiichi Sankyo Co Ltd |
Enlazadores para conjugados de anticuerpo - fármaco
|
|
JP2016500367A
(ja)
|
2012-12-05 |
2016-01-12 |
デュタリス ゲーエムベーハー |
デュアルターゲティング
|
|
WO2015012904A2
(en)
|
2012-12-13 |
2015-01-29 |
Immunomedics, Inc. |
Antibody-sn-38 immunoconjugates with a cl2a linker
|
|
US20160326263A1
(en)
|
2013-02-20 |
2016-11-10 |
Minerva Biotechnologies Corporation |
NME Inhibitors and Methods of Using NME Inhibitors
|
|
CA2901893C
(en)
|
2013-02-20 |
2022-08-30 |
Minerva Biotechnologies Corporation |
Nme inhibitors and methods of using nme inhibitors
|
|
AU2014306778B2
(en)
|
2013-08-12 |
2020-10-29 |
Minerva Biotechnologies Corporation |
Method for enhancing tumor growth
|
|
WO2015116753A1
(en)
|
2014-01-29 |
2015-08-06 |
Dana-Farber Cancer Institute, Inc. |
Antibodies against the muc1-c/extracellular domain (muc1-c/ecd)
|
|
AU2015243948B2
(en)
|
2014-04-07 |
2020-10-15 |
Minerva Biotechnologies Corporation |
Anti-NME antibody
|
|
CN116199790A
(zh)
|
2015-02-10 |
2023-06-02 |
米纳瓦生物技术公司 |
人源化抗MUCl*抗体
|
|
US20170106046A1
(en)
|
2015-03-03 |
2017-04-20 |
Minerva Biotechnologies Corporation |
Method for diagnosing and treating cancer using naive state stem cell specific genes
|
|
US20180235193A1
(en)
|
2015-07-01 |
2018-08-23 |
Minerva Biotechnologies Corporation |
Method of stem cell-based organ and tissue generation
|
|
US11931347B2
(en)
|
2015-09-23 |
2024-03-19 |
Minerva Biotechnologies Corporation |
Method of screening for agents for differentiating stem cells
|
|
EP3442592A4
(en)
|
2016-04-13 |
2019-11-27 |
Tarveda Therapeutics, Inc. |
NEUROTENSIN RECEPTOR BINDING CONJUGATES AND FORMULATIONS THEREOF
|
|
CA3039797A1
(en)
|
2016-10-11 |
2018-04-19 |
Minerva Biotechnologies Corporation |
Humanized anti-muc1* antibodies and use of cleavage enzyme
|
|
KR102127421B1
(ko)
|
2017-03-21 |
2020-06-26 |
주식회사 펩트론 |
Muc1에 특이적으로 결합하는 항체 및 그의 용도
|
|
EP3600451B1
(en)
|
2017-03-29 |
2025-12-24 |
Minerva Biotechnologies Corporation |
Agents for differentiating stem cells and treating cancer
|
|
WO2019104306A1
(en)
|
2017-11-27 |
2019-05-31 |
Minerva Biotechnologies Corporation |
Humanized anti-muc1* antibodies and direct use of cleavage enzyme
|
|
WO2019126357A1
(en)
|
2017-12-19 |
2019-06-27 |
Minerva Biotechnologies Corporation |
Agents for treating cancer and methods for identifying said agents
|
|
JP7416695B2
(ja)
|
2017-12-29 |
2024-01-17 |
メモリアル スローン－ケタリング キャンサー センター |
増強されたキメラ抗原受容体およびその使用
|
|
EP3759145A4
(en)
|
2018-02-26 |
2022-03-09 |
Minerva Biotechnologies Corporation |
DIAGNOSTIC METHODS USING ANTI-MUC1* ANTIBODIES
|
|
US20200405832A1
(en)
|
2018-03-09 |
2020-12-31 |
Minerva Biotechnologies Corporation |
Method for anti-muc1* car t cell stimulation
|
|
SG11202010496WA
(en)
*
|
2018-05-18 |
2020-12-30 |
Daiichi Sankyo Co Ltd |
Anti-muc1 antibody-drug conjugate
|
|
TWI851577B
(zh)
|
2018-06-07 |
2024-08-11 |
美商思進公司 |
喜樹鹼結合物
|
|
KR102905497B1
(ko)
*
|
2018-12-11 |
2025-12-30 |
다이이찌 산쿄 가부시키가이샤 |
항체-약물 컨쥬게이트와 parp 저해제의 조합
|
|
CN120484122A
(zh)
|
2019-01-11 |
2025-08-15 |
米纳瓦生物技术公司 |
抗可变muc1*抗体及其用途
|
|
EP3920693A4
(en)
|
2019-02-04 |
2022-10-05 |
Minerva Biotechnologies Corporation |
ANTI-NME ANTIBODIES AND METHODS OF TREATMENT OF CANCER OR CANCER METASTASIS
|
|
EP3936150A4
(en)
|
2019-03-06 |
2023-03-29 |
LegoChem Biosciences, Inc. |
ANTIBODY-DRUG CONJUGATES COMPRISING ANTIBODY AGAINST HUMAN DLK1 AND USE THEREOF
|
|
CA3085001C
(en)
|
2019-05-20 |
2021-10-05 |
Mabplex International, Ltd. |
One-pot process for preparing intermediate of antibody-drug conjugate
|
|
CN113766933B
(zh)
|
2019-06-28 |
2024-09-06 |
上海复旦张江生物医药股份有限公司 |
一种抗体偶联药物、其中间体、制备方法及应用
|
|
CN114667134A
(zh)
|
2019-08-15 |
2022-06-24 |
希沃尔拜克治疗公司 |
苯并氮杂䓬缀合物的制剂及其用途
|
|
EP4096717B1
(en)
|
2020-01-31 |
2024-12-11 |
Innate Pharma |
Treatment of cancer
|
|
WO2021242935A1
(en)
|
2020-05-26 |
2021-12-02 |
Cue Biopharma, Inc. |
Antigen presenting polypeptide complexes and methods of use thereof
|
|
EP4161970A4
(en)
|
2020-06-08 |
2024-07-10 |
Minerva Biotechnologies Corporation |
ANTI-NME ANTIBODIES AND METHODS FOR TREATING CANCER OR CANCER METASTASES
|
|
CA3183682A1
(en)
|
2020-06-26 |
2021-12-30 |
Minerva Biotechnologies Corporation |
Anti-nme antibody and method of treating cancer or cancer metastasis
|
|
US12104170B2
(en)
|
2020-06-26 |
2024-10-01 |
Minerva Biotechnologies Corporation |
Methods for deriving dopaminergic neurons from pluripotent stem cells
|
|
IL299834A
(en)
*
|
2020-07-14 |
2023-03-01 |
Cue Biopharma Inc |
with binding sites and methods for using them T - cellular modulatory polypeptides
|
|
AU2021316042A1
(en)
|
2020-07-29 |
2023-03-30 |
Minerva Biotechnologies Corporation |
Anti-variable MUC1* antibodies and uses thereof
|
|
CN119317447A
(zh)
|
2022-04-12 |
2025-01-14 |
米纳瓦生物技术公司 |
抗可变muc1*抗体及其用途
|
|
WO2023220560A1
(en)
|
2022-05-09 |
2023-11-16 |
Minerva Biotechnologies Corporation |
Chimeric antigen receptor and il-18 receptor compositions and methods of use therein
|
|
US20240261406A1
(en)
|
2023-02-02 |
2024-08-08 |
Minerva Biotechnologies Corporation |
Chimeric antigen receptor compositions and methods for treating muc1* diseases
|
|
WO2025049494A1
(en)
|
2023-08-29 |
2025-03-06 |
Minerva Biotechnologies Corporation |
Bacterial nme7 orthologs and uses thereof
|
|
US20250121088A1
(en)
|
2023-10-11 |
2025-04-17 |
Minerva Biotechnologies Corporation |
Anti-muc1* antibody drug complexes and uses thereof
|